PathologybioRxiv
Pre-clinical evaluation of antiviral activity of nitazoxanide against Sars-CoV-2
J.-S. Driouich, M. Cochin, F. Touret…·A. Nougairede
This study evaluates nitazoxanide's antiviral activity against SARS-CoV-2 in vitro and in vivo, finding that its standard dosage is ineffective due to insufficient drug concentration in target organs.